Baxter International Inc.
BAX
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug platforms, inhaled anesthesia and critical care productā¦ read more
Healthcare
Medical Instruments & Supplies
43 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$23.61
Price-2.36%
-$0.57
1Y
Price
Market Cap
$12.127b
Large
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years+6.8%
EBITDA Margin+3.2%
Net Profit Margin-11.2%
Free Cash Flow MarginRevenue
$10.887b
+2.4%
1y CAGR+2.7%
3y CAGR-2.3%
5y CAGREarnings
-$155m
+76.1%
1y CAGR+53.6%
3y CAGR-32.2%
5y CAGREPS
-$0.29
+77.2%
1y CAGR+53.7%
3y CAGR-32.4%
5y CAGRBook Value
$7.054b
$21.304b
Assets$14.250b
Liabilities$10.309b
DebtDebt to Assets
48.4%
16.1x
Debt to EBITDAFree Cash Flow
$191m
-65.8%
1y CAGR+0.5%
3y CAGR-15.2%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company